CVS Health Corp vs Prudential Financial Inc — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.49B), while Prudential Financial Inc trades at $114.08 (market cap $38.76B). The key difference: CVS Health Corp is far larger — about 2.9× Prudential Financial Inc's market cap, and Prudential Financial Inc pays the higher dividend (4.98%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Prudential Financial Inc for 145 Days on average.
| CVS | PRU | |
|---|---|---|
Market Cap | $112.49B | $38.76B |
Volume | 8,467,392 | 1,604,078 |
Sector | Health | Financials |
52-Week High | $110.60 | $125.13 |
52-Week Low | $70.08 | $92.00 |
Typical Hold Time | 83 Days | 145 Days |
Enterprise Value | $174.83B | $67.54B |
Dividend Yield | 3.02% | 4.98% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Prudential Financial (PRU) trades at $113.53, down slightly by 0.01%. The stock exhibits a bearish technical trend with key support at $110, while fundamentals show a P/E of 10.19 and net income margin of 6.04%. Recent earnings beat expectations in Q1 and Q2 2026, and the company announced a strategic $3 billion capital rotation and $750 million cost savings plan (MarketBeat, 2026-09-17).
The outlook is mixed: valuation appears attractive with low P/E and P/S ratios, and higher interest rates may boost investment income. However, analyst consensus is cautious with a $105.67 price target below current levels, and technical indicators signal bearish pressure. Risks include execution of strategic initiatives and macroeconomic sensitivity.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →